 PONTE VEDRA, Fla., Dec. 20, 2022 GLOBE NEWSWIRE -- Treace Medical Concepts, Inc. Treace or the Company NasdaqGS: TMCI, a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus commonly known as bunions through its Lapiplasty 3D Bunion CorrectionTM Procedure, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will present the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 10:30 a.m. Eastern Time. 